Zobrazeno 1 - 1
of 1
pro vyhledávání: '"MESH: Saliva, Artificial"'
Autor:
Ramos-Casals, M., Brito-Zeron, P., Bombardieri, S., Bootsma, H., De Vita, S., Dorner, T., Fisher, B. A., Gottenberg, J. -E., Hernandez-Molina, G., Kocher, A., Kostov, B., Kruize, A. A., Mandl, T., W. -F., Ng, Retamozo, S., Seror, R., Shoenfeld, Y., Siso-Almirall, A., Tzioufas, A. G., Vitali, C., Bowman, S., EULAR-Sjögren Syndrome Task Force Group: Sebastian A, Mariette X., Saraux, A, Vissink, A, Rasmussen, A, Hofauer, B, Armagan, B, Feijoo-Massó, C, Shiboski, Ch, Baldini, C, Vollenweider, C, Sene, D, Hammenfors, D, Isenberg, D, Danda, D, Bartoloni, E
Publikováno v:
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2019, 79 (1), pp.3-18. ⟨10.1136/annrheumdis-2019-216114⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, 79 (1), pp.3-18. ⟨10.1136/annrheumdis-2019-216114⟩
Universitat Politècnica de Catalunya (UPC)
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2019, 79 (1), pp.3-18. ⟨10.1136/annrheumdis-2019-216114⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, 79 (1), pp.3-18. ⟨10.1136/annrheumdis-2019-216114⟩
International audience; The therapeutic management of Sjögren syndrome (SjS) has not changed substantially in recent decades: treatment decisions remain challenging in clinical practice, without a specific therapeutic target beyond the relief of sym